ET
ETST.US Earth Science Tech Inc
- Market cap
- USD 27.2M
- P/E
- 9.5x
- P/B
- 3.71x
- ROE
- 38.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.
Is ETST.US undervalued?
Graham numberETST.US trades 25.0% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Earth Science Tech Inc fundamental analysis
No fundamental analysis for Earth Science Tech Inc yet.
Earth Science Tech Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Earth Science Tech Inc
Earth Science Tech, Inc., together with its subsidies, focuses on health and wellness industry. It engages in vertically integrated healthcare platforms that combines compounding pharmacy operations, telemedicine platforms, clinical support, and patient fulfillment. It is also involved in investments in real estate and asset management activities, and consumer products business. It also operates multi-state sterile non-sterile compounding for specialized therapies through Rx…
Full company profileEarth Science Tech Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Earth Science Tech Inc annual financial statements
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 428K | 463K | 771K | 526K | 141K | 14.1K | 48.5K | 12.0M | 33.1M | 35.7M | 32.7M |
| Gross Profit | 184K | 193K | 295K | 218K | 39.9K | -8.52K | 22.1K | 7.83M | 24.3M | 25.5M | 10.2M |
| Operating Income | -10.1M | -1.61M | -1.62M | -824K | -433K | -219K | -937K | 1.32M | 3.45M | 4.31M | 3.20M |
| EBITDA | -1.13M | -1.69M | -2.13M | -875K | -4.30M | -219K | -382K | 1.47M | 3.54M | 3.39M | 3.50M |
| Net Income | -1.15M | -1.74M | -2.22M | -1.54M | -4.38M | 3.17M | -365K | 812K | 3.25M | 3.63M | 3.11M |
| EPS | -0.03 | -0.04 | -0.04 | -0.04 | -0.09 | 0.06 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
| Balance Sheet | |||||||||||
| Total Assets | 427K | 345K | 411K | 155K | 64.6K | 76.9K | 2.73M | 3.88M | 7.07M | 8.97M | 10.9M |
| Total Liabilities | 418K | 429K | 618K | 980K | 5.09M | 1.88M | 1.61M | 1.63M | 3.22M | 1.93M | 2.78M |
| Shareholders' Equity | 9.35K | -84.0K | -207K | -825K | -5.03M | -1.81M | 1.12M | 2.25M | 3.85M | 7.01M | 8.05M |
| Cash & Short-term Investments | 172K | 72.0K | 128K | 30.7K | 16.2K | 26.9K | 35.8K | 698K | 2.12M | 2.16M | 2.66M |
| Total Debt | 59.6K | 59.6K | 203K | 499K | 650K | 781K | 974K | 247K | 401K | 96.2K | 444K |
| Cash Flow | |||||||||||
| Operating Cash Flow | -1.14M | -1.68M | -1.64M | -519K | -197K | -168K | -1.01M | 1.21M | 4.37M | 1.94M | 1.69M |
| Capital Expenditure | 146.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.71K | 0.00 | 26.5K | 753K | 757K | 786K |
| Free Cash Flow | -1.14M | -1.68M | -1.64M | -519K | -197K | -166K | -1.01M | 1.18M | 3.62M | 1.18M | 2.04M |
| Ratios | |||||||||||
| ROE | -12,261.8% | - | - | - | - | - | -32.6% | 36.1% | 84.5% | 51.8% | 38.6% |
| ROA | -268.2% | -503.4% | -538.9% | -999.0% | -6,788.9% | 4,124.2% | -13.4% | 20.9% | 46.0% | 40.5% | 28.6% |
| Net Profit Margin | -267.7% | -375.4% | -287.5% | -293.5% | -3,110.8% | 22,468.7% | -752.8% | 6.8% | 9.8% | 10.2% | 9.5% |
| Debt to Equity | 6.37x | - | - | - | - | - | 0.87x | 0.11x | 0.10x | 0.01x | 0.06x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Earth Science Tech Inc dividends
Earth Science Tech Inc has not paid dividends in the last 9 fiscal years.
Who owns Earth Science Tech Inc
- Insiders 66.91%
- Institutions 0.00%
- Public & others 33.09%
- Shares outstanding 288M
- Free float 96.0M
Earth Science Tech Inc company profile
- Company name
- Earth Science Tech Inc
- Ticker
- ETST.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 77
- Fiscal year end
- March
- Address
- 8950 Southwest 74th Court, Miami, FL, United States, 33156
- Phone
- 305 724 5684
- Website
- earthsciencetech.com
About Earth Science Tech Inc
Earth Science Tech, Inc., together with its subsidies, focuses on health and wellness industry. It engages in vertically integrated healthcare platforms that combines compounding pharmacy operations, telemedicine platforms, clinical support, and patient fulfillment. It is also involved in investments in real estate and asset management activities, and consumer products business. It also operates multi-state sterile non-sterile compounding for specialized therapies through RxCompoundStore.com; mister meds sterile and hazardous compounding center under the Mister Meds name; frictionless asynchronous consults funneling to licensed pharmacies; under the Peaks Curative brand name; virtual care brand for home-based therapies under the DOConsultations brand name; and brick-and-mortar healthcare facility under the Villas Health Care brand name. In addition, it is involved in the development, asset management, and financing under the Avenvi brand name; and provides direct-to-consumer retail under the MagneChef brand name. The company was formerly known as Ultimate Novelty Sports, Inc. and changed its name to Earth Science Tech, Inc. in March 2014. Earth Science Tech, Inc. was incorporated in 2010 and is headquartered in Miami, Florida.
Earth Science Tech Inc management
4- Mr. Giorgio R. SaumatChairman, CEO, CFO & Chief Accounting Officer · born 1980
- Mr. Mario G. TabraueCOO & Director · born 1979
- Mr. Christopher RoseChief Technology Officer · born 1977
- Ms. Victoria LosadaTreasurer, Secretary & Director · born 1996